Adrenal disease

Comparison of salivary cortisol, cortisone, and dexamethasone with serum measurements across dynamic adrenal testing

J Clin Endocrinol MetabPublished Cross-sectional study

Authors' conclusion

These findings support saliva-based dynamic adrenal testing and identify clinically relevant salivary thresholds.

Study context

Population
Adults undergoing dynamic adrenal testing at a tertiary referral center640 participants
Participants
473 / 163 / 11
Exposure
Salivary cortisol, cortisone and dexamethasone vs serum measurements during dynamic adrenal testing
  • Dexamethasone suppression testing (DST)n = 473
  • Cosyntropin stimulation testing (CST)n = 163
  • Overnight metyrapone testing (OMT)n = 11
Outcome
Correlation of salivary with serum measurements
Methodological detailstertiary referral center
  • Tertiary referral center

Main finding

As reported in the abstract

Salivary cortisone vs serum cortisol after 1-mg DST, r

0.86

Salivary cortisol vs serum cortisol after 1-mg DST, r (both P < 0.001)

0.53

Salivary cortisol and cortisone vs serum cortisol during CST, r (all P < 0.001)

0.75-0.87

Salivary vs serum dexamethasone, r (P < 0.001)

0.61

Observational data: associations, not effects.

Further findings

Salivary cortisone thresholds corresponding to serum cortisol 1.8, 5, 10 and 18 µg/dL (50, 138, 276 and 497 nmol/L)

Salivary cortisone thresholds, ng/dL
117, 329, 585, and 1262
Salivary cortisone thresholds, nmol/L
3.25, 9.13, 16.23, and 35.01

Salivary cortisol thresholds corresponding to serum cortisol 1.8, 5, 10 and 18 µg/dL

Salivary cortisol thresholds, ng/dL
16.5, 38, 80, and 278
Salivary cortisol thresholds, nmol/L
0.46, 1.05, 2.21, and 7.67

Original publication

Comparison of salivary cortisol, cortisone, and dexamethasone with serum measurements across dynamic adrenal testing. J Clin Endocrinol Metab. Published 26 September 2026. doi:10.1210/clinem/dgag393

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.